vs
Side-by-side financial comparison of Inogen Inc (INGN) and Phreesia, Inc. (PHR). Click either name above to swap in a different company.
Phreesia, Inc. is the larger business by last-quarter revenue ($120.3M vs $68.6M, roughly 1.8× Inogen Inc). On growth, Phreesia, Inc. posted the faster year-over-year revenue change (12.7% vs 3.4%). Phreesia, Inc. produced more free cash flow last quarter ($12.2M vs $-1.9M).
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
Phreesia, Inc. is a software as a service company that offers healthcare organizations a set of applications to automate and manage patient intake.
INGN vs PHR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | ||
|---|---|---|
| Revenue | $68.6M | $120.3M |
| Net Profit | — | $4.3M |
| Gross Margin | 51.4% | — |
| Operating Margin | -13.6% | 3.1% |
| Net Margin | — | 3.5% |
| Revenue YoY | 3.4% | 12.7% |
| Net Profit YoY | — | 129.7% |
| EPS (diluted) | $-0.26 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $68.6M | $120.3M | ||
| Q3 25 | $79.1M | $117.3M | ||
| Q2 25 | $79.2M | $115.9M | ||
| Q1 25 | $68.5M | — | ||
| Q4 24 | $66.3M | — | ||
| Q3 24 | $74.9M | — | ||
| Q2 24 | $74.4M | — | ||
| Q1 24 | $63.1M | — |
| Q4 25 | — | $4.3M | ||
| Q3 25 | $-5.3M | $654.0K | ||
| Q2 25 | $-4.2M | $-3.9M | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-5.6M | — | ||
| Q1 24 | $-14.6M | — |
| Q4 25 | 51.4% | — | ||
| Q3 25 | 52.2% | — | ||
| Q2 25 | 52.2% | — | ||
| Q1 25 | 53.1% | — | ||
| Q4 24 | 54.7% | — | ||
| Q3 24 | 55.2% | — | ||
| Q2 24 | 57.4% | — | ||
| Q1 24 | 54.5% | — |
| Q4 25 | -13.6% | 3.1% | ||
| Q3 25 | -9.0% | -1.3% | ||
| Q2 25 | -7.7% | -2.8% | ||
| Q1 25 | -11.2% | — | ||
| Q4 24 | -17.2% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -9.5% | — | ||
| Q1 24 | -25.8% | — |
| Q4 25 | — | 3.5% | ||
| Q3 25 | -6.7% | 0.6% | ||
| Q2 25 | -5.2% | -3.4% | ||
| Q1 25 | -9.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.0% | — | ||
| Q2 24 | -7.5% | — | ||
| Q1 24 | -23.1% | — |
| Q4 25 | $-0.26 | $0.07 | ||
| Q3 25 | $-0.20 | $0.01 | ||
| Q2 25 | $-0.15 | $-0.07 | ||
| Q1 25 | $-0.25 | — | ||
| Q4 24 | $-0.41 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.24 | — | ||
| Q1 24 | $-0.62 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.7M | $106.4M |
| Total DebtLower is stronger | — | $3.4M |
| Stockholders' EquityBook value | $192.2M | $320.3M |
| Total Assets | $298.6M | $423.5M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $103.7M | $106.4M | ||
| Q3 25 | $106.5M | $98.3M | ||
| Q2 25 | $103.7M | $90.9M | ||
| Q1 25 | $118.9M | — | ||
| Q4 24 | $113.8M | — | ||
| Q3 24 | $105.7M | — | ||
| Q2 24 | $97.9M | — | ||
| Q1 24 | $107.4M | — |
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | $4.6M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $192.2M | $320.3M | ||
| Q3 25 | $197.2M | $298.0M | ||
| Q2 25 | $199.5M | $282.2M | ||
| Q1 25 | $198.0M | — | ||
| Q4 24 | $173.9M | — | ||
| Q3 24 | $185.4M | — | ||
| Q2 24 | $187.6M | — | ||
| Q1 24 | $191.9M | — |
| Q4 25 | $298.6M | $423.5M | ||
| Q3 25 | $307.0M | $408.6M | ||
| Q2 25 | $312.0M | $400.4M | ||
| Q1 25 | $308.4M | — | ||
| Q4 24 | $296.2M | — | ||
| Q3 24 | $306.2M | — | ||
| Q2 24 | $308.9M | — | ||
| Q1 24 | $315.6M | — |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-943.0K | $15.5M |
| Free Cash FlowOCF − Capex | $-1.9M | $12.2M |
| FCF MarginFCF / Revenue | -2.8% | 10.1% |
| Capex IntensityCapex / Revenue | 1.4% | 2.7% |
| Cash ConversionOCF / Net Profit | — | 3.62× |
| TTM Free Cash FlowTrailing 4 quarters | $-13.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-943.0K | $15.5M | ||
| Q3 25 | $2.2M | $14.8M | ||
| Q2 25 | $4.3M | $14.8M | ||
| Q1 25 | $-16.8M | — | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $7.0M | — | ||
| Q2 24 | $6.7M | — | ||
| Q1 24 | $-4.7M | — |
| Q4 25 | $-1.9M | $12.2M | ||
| Q3 25 | $1.6M | $13.1M | ||
| Q2 25 | $3.7M | $11.3M | ||
| Q1 25 | $-17.1M | — | ||
| Q4 24 | $-3.3M | — | ||
| Q3 24 | $5.3M | — | ||
| Q2 24 | $6.6M | — | ||
| Q1 24 | $-6.1M | — |
| Q4 25 | -2.8% | 10.1% | ||
| Q3 25 | 2.0% | 11.1% | ||
| Q2 25 | 4.6% | 9.8% | ||
| Q1 25 | -24.9% | — | ||
| Q4 24 | -5.0% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 8.9% | — | ||
| Q1 24 | -9.6% | — |
| Q4 25 | 1.4% | 2.7% | ||
| Q3 25 | 0.7% | 1.5% | ||
| Q2 25 | 0.9% | 3.0% | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | — | 3.62× | ||
| Q3 25 | — | 22.68× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
PHR
| Subscription And Services | $55.5M | 46% |
| Network Solutions | $37.4M | 31% |
| Payment Processing Fees | $27.4M | 23% |